Medical News

RSS

Study shows value-based plans can improve adherence for diabetes medicines

A study by CVS Caremark (NYSE: CVS), published this week in the American Journal of Pharmacy Benefits, finds that insurance benefit designs that reduce the cost of medications for plan participants result in patients being more likely to start and stay on their medication therapy.

17 Feb 2010

As politics swirl, both sides prepare for health care summit

With the White House health summit quickly approaching, members from both sides of the aisle "are pressing story lines on how the reform debate has played out that aren't as tidy or truthful as Democrats and Republicans would like voters to believe," Politico reports. "The summit could help reset the negotiations, but with [President Barack] Obama, Vice President Joe Biden, other top administration officials and 37 lawmakers all in attendance, the likelihood of a serious breakthrough appears dim."

17 Feb 2010

NanoViricides signs research and development agreement with Dr. Eva Harris’s laboratory at UC Berkeley

NanoViricides, Inc. (the "Company"), reports that it has signed a research and development agreement with Dr. Eva Harris’s laboratory at the University of California, Berkeley (UC Berkeley).

17 Feb 2010

Controlled utility study results of BGM Galectin-3 test for heart failure published in cardiology journal

BG Medicine, Inc. announced today that the results of a controlled study on the utility of its galectin-3 test in heart failure were published in the Journal Clinical Research in Cardiology, a peer-reviewed, international journal that publishes original research and review articles on clinical research studies in the field of cardiology.

17 Feb 2010

AP examines male circumcision efforts in Africa, including adult circumcision devices

The Associated Press examines efforts to prevent the spread of HIV by circumcising "about 50 million men across Africa - where 70 percent of the world's HIV-infected population lives."

17 Feb 2010

Majority of Americans support conservation, but few practice it in everyday lives

Most Americans like the idea of conservation, but few practice it in their everyday lives, according to the results of a national survey released today by researchers at Yale and George Mason universities.

17 Feb 2010

MIT announces the publication of major research report of its symbol MDLH

Medical International Technology Inc. www.mitneedlefree.com is pleased to announce the publication of a major research report of its symbol MDLH by Grass Roots Research and Distribution, Inc.

17 Feb 2010

Delayed introduction of complementary baby foods may influence weight: Study

Benjamin Franklin's advice that "an ounce of prevention is worth a pound of cure" can easily be applied to today's most pressing health issue: obesity. Because taking off extra weight is an almost insurmountable challenge, preventing the progression of weight gain throughout life, especially childhood, is crucial to realizing optimal long-term health.

17 Feb 2010

Bedford Laboratories launches Indomethacin for Injection

Bedford Laboratories™, a division of Ben Venue Laboratories, Inc., a provider of select specialty injectables, is pleased to announce the addition of Indomethacin for Injection to its existing product line. This product is AP rated and is equivalent to Indocin® by Lundbeck, Inc. Indomethacin for Injection is indicated to close a hemodynamically significant patent ductus arteriosus in premature infants weighing between 500 and 1750 g when after 48 hours usual medical management (e.g., fluid restriction, diuretics, digitalis, respiratory support, etc.) is ineffective.

17 Feb 2010

New fluorescent probes improve tumor detection in mice

Building on his Nobel Prize-winning work creating fluorescent proteins that light up the inner workings of cells, a team of researchers led by Howard Hughes Medical Institute investigator Roger Tsien, PhD, professor of pharmacology, chemistry and biochemistry at the University of California, San Diego and the Moores UCSD Cancer Center has developed biological probes that can stick to and light up tumors in mice.

17 Feb 2010

New DNA: Dynamic NextGen Analytics platform now available from IntegriChain

IntegriChain, Inc., a commercial insight provider supporting the pharmaceutical industry, announces the launch of its new DNA: Dynamic NextGen Analytics™ (DNA) platform.

17 Feb 2010

Two prominent Georgia physicians call for Senate action to stop 21% Medicare cut

Making a plea to Senators Saxby Chambliss and Johnny Isakson, two prominent Georgia physicians who head national physician organizations joined with American Medical Association (AMA) President J. James Rohack, M.D. to call for Senate action this month to stop a 21 percent Medicare cut that will hurt seniors and military families on March 1.

17 Feb 2010

Even with new medical schools opening, shortages mar workforce

Nearly two dozen medical schools have recently opened or may open across America, "the most at any time since the 1960s and '70s," The New York Times reports. These new institutions "are seeking to address an imbalance in American medicine that has been growing for a quarter century. Many bright students were fleeing to offshore medical schools, or giving up hope entirely, when they could not get into domestic schools. Meanwhile, American hospitals were using foreign-trained and foreign-born physicians to fill medical residencies. During the 1980s and '90s only one new medical school was established."

17 Feb 2010

CMAJ study: Increased dosage of Tamiflu required in treating H1N1 influenza patients

An increased dosage of Tamiflu (oseltamivir) for patients with critical illness is unlikely to be required in the treatment of pandemic (H1N1) influenza, contrary to current international guidelines, found a new study http://www.cmaj.ca/cgi/doi/10.1503/cmaj.092127 in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.

17 Feb 2010

Amgen and Centocor Ortho Biotech Products: FDA approves REMS for Aranesp, EPOGEN and PROCRIT ESAs

Amgen Inc. and Centocor Ortho Biotech Products, L.P., today announced that the U.S. Food and Drug Administration (FDA) has approved the Risk Evaluation and Mitigation Strategy (REMS) for erythropoiesis-stimulating agents (ESAs), which include Aranesp® (darbepoetin alfa), EPOGEN® (Epoetin alfa) and PROCRIT® (Epoetin alfa).

17 Feb 2010

Special issue reviews current state of science in fetal therapy

Repairing birth defects in the womb. Inserting a tiny laser into the mother's uterus to seal off an abnormal blood flow and save fetal twins. Advancing the science that may allow doctors to deliver cells or DNA to treat sickle cell anemia and other genetic diseases before birth.

17 Feb 2010

Amid stalled health reform efforts, advocates emerge for the state-by-state approach

Proponents of state-based health reform are saying that the federal stall over a health overhaul is giving states a perfect opportunity to showcase what they can do to solve the health care cost and coverage crisis, The Washington Post reports.

17 Feb 2010

National symposium aims to attract more women for a rewarding career in surgery

While interviewing for postgraduate residency positions soon after giving birth to her third child, Dr. Sharona Ross recalls, she was very hesitant to bring up her infant and two small children at home. She thought it would hurt her chances for a career in surgery.

17 Feb 2010

Quark Pharmaceuticals' QPI-1002 receives orphan drug designation from FDA

Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, announced today that the US FDA has granted orphan drug designation for QPI-1002 (also referred to as "I5NP"), a synthetic siRNA targeting p53 mRNA for the prophylaxis of delayed graft function (DGF) in kidney transplant patients.

17 Feb 2010

Sequenom CMM launches SensiGene Fetal Sex Determination test

Sequenom, Inc. today announced the launch of the SensiGene™ Fetal(XY) (Fetal Sex Determination) test by Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM). This is the company's second laboratory developed test powered by its SEQureDx™ technology.

17 Feb 2010

Medical News

Study shows value-based plans can improve adherence for diabetes medicines

As politics swirl, both sides prepare for health care summit

NanoViricides signs research and development agreement with Dr. Eva Harris’s laboratory at UC Berkeley

Controlled utility study results of BGM Galectin-3 test for heart failure published in cardiology journal

AP examines male circumcision efforts in Africa, including adult circumcision devices

Majority of Americans support conservation, but few practice it in everyday lives

MIT announces the publication of major research report of its symbol MDLH

Delayed introduction of complementary baby foods may influence weight: Study

Bedford Laboratories launches Indomethacin for Injection

New fluorescent probes improve tumor detection in mice

New DNA: Dynamic NextGen Analytics platform now available from IntegriChain

Two prominent Georgia physicians call for Senate action to stop 21% Medicare cut

Even with new medical schools opening, shortages mar workforce

CMAJ study: Increased dosage of Tamiflu required in treating H1N1 influenza patients

Amgen and Centocor Ortho Biotech Products: FDA approves REMS for Aranesp, EPOGEN and PROCRIT ESAs

Special issue reviews current state of science in fetal therapy

Amid stalled health reform efforts, advocates emerge for the state-by-state approach

National symposium aims to attract more women for a rewarding career in surgery

Quark Pharmaceuticals' QPI-1002 receives orphan drug designation from FDA

Sequenom CMM launches SensiGene Fetal Sex Determination test

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News